WallStreetZenWallStreetZen

NASDAQ: PHIO
Phio Pharmaceuticals Corp Stock Ownership - Who owns Phio Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Phio Pharmaceuticals Corp insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Robert J. BittermanChairman Pres. CEO2025-11-215,000$1.14
$5.70kBuy
Robert J. BittermanChairman Pres. CEO2025-11-185,000$1.27
$6.35kBuy
Robert J. BittermanChairman Pres. CEO2025-09-114,111$2.32
$9.54kSell
Robert L. FerraraDirector2025-06-102,500$2.42
$6.05kBuy
Robert J. BittermanChairman Pres CEO2025-06-102,000$2.42
$4.84kBuy
Robert J. BittermanChairman Pres CEO2025-06-091,500$2.75
$4.13kBuy
Robert J. BittermanChairman Pres CEO2025-05-221,200$1.78
$2.14kBuy
Robert J. BittermanChairman Pres CEO2025-05-213,000$1.77
$5.31kBuy
Robert L. FerraraDirector2025-05-202,500$1.82
$4.55kBuy

1 of 1

PHIO insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PHIO insiders and whales buy or sell their stock.

PHIO Shareholders

What type of owners hold Phio Pharmaceuticals Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Opko Health Inc624.66%67,241,380$75.31MInsider
Sellas Life Sciences Group Inc300.93%32,393,095$36.28MInsider
Advanced Rna Technologies LLC11.35%1,221,723$1.37MInsider
Alexey Eliseev8.83%950,312$1.06MInsider
Robert J. Bitterman2.61%281,421$315.19kInsider
John A. Barrett2.07%222,991$249.75kInsider
Gerrit Dispersyn1.97%212,327$237.81kInsider
Vanguard Group Inc0.81%87,628$98.14kInstitution
Geode Capital Management LLC0.54%57,906$64.85kInstitution
Lisa Cabott Carson0.44%47,000$52.64kInsider

1 of 3

PHIO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PHIO0.18%99.82%Net BuyingNet Buying
PLRZ1.26%0.00%
VYNE12.04%78.86%Net SellingNet Selling
ICU3.03%37.18%Net BuyingNet Buying
IMNN1.72%98.28%Net Buying
View Top Biotech Stocks

Phio Pharmaceuticals Stock Ownership FAQ

Who owns Phio Pharmaceuticals?

Phio Pharmaceuticals (NASDAQ: PHIO) is owned by 1.75% institutional shareholders, 954.71% Phio Pharmaceuticals insiders, and 0.00% retail investors. Opko Health Inc is the largest individual Phio Pharmaceuticals shareholder, owning 67.24M shares representing 624.66% of the company. Opko Health Inc's Phio Pharmaceuticals shares are currently valued at $75.31M.

If you're new to stock investing, here's how to buy Phio Pharmaceuticals stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.